Citations (241)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Yarong Zeng, Feihong Zou, Ningshao Xia & Shaowei Li. (2023) In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Review of Vaccines 22:1, pages 681-695.
Read now
Read now
Kirk Hofman, Gautam N. Shenoy, Vincent Chak & Sathy V. Balu-Iyer. (2021) Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines. Immunological Investigations 50:7, pages 743-779.
Read now
Read now
Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani & Azam Bolhassani. (2021) The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Review of Vaccines 20:7, pages 839-855.
Read now
Read now
Zhuofan Li, Wenting Ding, Qi Guo, Ze Liu, Zhe Zhu, Shaohui Song, Weidong Li & Guoyang Liao. (2018) Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV). Human Vaccines & Immunotherapeutics 14:8, pages 1987-1994.
Read now
Read now
John S. Tregoning, Ryan F. Russell & Ekaterina Kinnear. (2018) Adjuvanted influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 550-564.
Read now
Read now
Aurelio Cruz-Valdez, Gabriel Valdez-Zapata, Sanjay S. Patel, Flavia V. Castelli, Marcia G. Garcia, Wim T. Jansen, Ashwani Kumar Arora & Esther Heijnen. (2018) MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico. Human Vaccines & Immunotherapeutics 14:2, pages 386-395.
Read now
Read now
Joseph J. Bivona$suffix/text()$suffix/text(), Sapna Patel & Michael Vajdy. (2017) Induction of cellular and molecular Immunomodulatory pathways by vitamin E and vitamin C. Expert Opinion on Biological Therapy 17:12, pages 1539-1551.
Read now
Read now
Nidhi Chauhan, Sukirti Tiwari, Tessy Iype & Utkarsh Jain. (2017) An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Expert Review of Vaccines 16:5, pages 491-502.
Read now
Read now
Camille Planty, Corey P. Mallett, Kevin Yim, Jorge C. G. Blanco, Marina Boukhvalova, Thomas March, Robbert van der Most & Eric Destexhe. (2017) Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats. Human Vaccines & Immunotherapeutics 13:1, pages 90-102.
Read now
Read now
Nathalie Garçon & Alberta Di Pasquale. (2017) From discovery to licensure, the Adjuvant System story. Human Vaccines & Immunotherapeutics 13:1, pages 19-33.
Read now
Read now
Vidyashankara Iyer, Corinne Cayatte, Bernardo Guzman, Kirsten Schneider-Ohrum, Ryan Matuszak, Angie Snell, Gaurav Manohar Rajani, Michael P McCarthy & Bilikallahalli Muralidhara. (2015) Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants. Human Vaccines & Immunotherapeutics 11:7, pages 1853-1864.
Read now
Read now
Fernanda Tavares Da Silva, Alberta Di Pasquale, Juan P Yarzabal & Nathalie Garçon. (2015) Safety assessment of adjuvanted vaccines: Methodological considerations. Human Vaccines & Immunotherapeutics 11:7, pages 1814-1824.
Read now
Read now
Alfonso Carmona Martinez, Ignacio Salamanca de la Cueva, Philippe Boutet, Carline Vanden Abeele, Igor Smolenov & Jeanne-Marie Devaster. (2014) A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months. Human Vaccines & Immunotherapeutics 10:7, pages 1959-1968.
Read now
Read now
Fazren Azmi, Abdullah Al Hadi Ahmad Fuaad, Mariusz Skwarczynski & Istvan Toth. (2014) Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human Vaccines & Immunotherapeutics 10:3, pages 778-796.
Read now
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Read now
Adele Mount, Sandra Koernig, Anabel Silva, Debbie Drane, Eugene Maraskovsky & Adriana Baz Morelli. (2013) Combination of adjuvants: the future of vaccine design. Expert Review of Vaccines 12:7, pages 733-746.
Read now
Read now
Larry R. Smith, Walter Wodal, Brian A. Crowe, Astrid Kerschbaum, Peter Bruehl, Michael G. Schwendinger, Helga Savidis-Dacho, Sean M. Sullivan, Mark Shlapobersky, Jukka Hartikka, Alain Rolland, P. Noel Barrett & Otfried Kistner. (2013) Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines. Human Vaccines & Immunotherapeutics 9:6, pages 1333-1345.
Read now
Read now
Articles from other publishers (224)
Maritsa Margaroni, Evgenia Tsanaktsidou, Maria Agallou, Costas Kiparissides, Olga Kammona & Evdokia Karagouni. (2024) Development of a novel squalene/α-tocopherol-based self-emulsified nanoemulsion incorporating Leishmania peptides for induction of antigen-specific immune responses. International Journal of Pharmaceutics 649, pages 123621.
Crossref
Crossref
Nicky Rahmana Putra, Ahmad Hazim Abdul Aziz, Dwila Nur Rizkiyah, Mohd Azizi Che Yunus, Ratna Surya Alwi & Lailatul Qomariyah. (2023) Green Extraction of Valuable Compounds from Rubber Seed Trees: A Path to Sustainability. Applied Sciences 13:24, pages 13102.
Crossref
Crossref
Federica Compostella, Laura Morelli & Luigi Lay. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
1
56
.
Meng-Qun Cheng, Rong Li, Xin Luo, Jing-Yu Chen, Zhong-Ping Bai, Pin Zhao, Zhi-Ying Weng & Gao Song. (2023) Immunogenicity and safety of adjuvant-associated COVID-19 vaccines: A systematic review and meta-analysis of randomized controlled trials. Heliyon 9:12, pages e22858.
Crossref
Crossref
Sivakumar S. Moni, Siddig Ibrahim Abdelwahab, Aamena Jabeen, Mohamed Eltaib Elmobark, Duaa Aqaili, Gassem Ghoal, Bassem Oraibi, Abdulla Mohammed Farasani, Ahmed Ali Jerah, Mahdi Mohammed A. Alnajai & Abdul Majeed Hamad Mohammad Alowayni. (2023) Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines 11:11, pages 1704.
Crossref
Crossref
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, Johannes Antony, Kwaku Poku Asante, Amit Suresh Bhate, Tatiana Beresnev, Matthew I Bonaparte, Médéric Celle, Maria Angeles Ceregido, Lawrence Corey, Dmytro Dobrianskyi, Bo Fu, Marie-Helene Grillet, Maryam Keshtkar-Jahromi, Michal Juraska, Jia Jin Kee, Hannah Kibuuka, Marguerite Koutsoukos, Roger Masotti, Nelson L Michael, Kathleen M Neuzil, Humberto Reynales, Merlin L Robb, Sandra M Villagómez Martínez, Fredrick Sawe, Lode Schuerman, Tina Tong, John Treanor, T Anh Wartel, Carlos A Diazgranados, Roman M Chicz, Sanjay Gurunathan, Stephen Savarino, Saranya Sridhar, Karina Abalos, Jose Accini, Naveena Aloysia, John Humphrey Amuasi, Nana Akosua Ansah, David Benkeser, Aude Berge, Hanna Beyko, Oleksandra Bilotkach, Thomas Breuer, Alberto Cadena Bonfanti, Elisabeth Bukusi, Richard Canter, Jaime Augusto Carrillo, Danaya Chansinghakul, Florence Coux, Chandan Das, Santa Kumar Das, Louis Devlin, Luis Espinoza, Michael Fay, Dean Follmann, Carina Frago, Agnes Garinga, Peter B Gilbert, Claudia Gonzalez, Maria Angelica Granados, Lea Guillery, Ying Huang, Kathy Hudzina, Manish Jain, Piush Kanodia, Nitin Khandelwal, Cissy Kityo Mutuluuza, Francis Kiweewa, Noah Kiwanuka, Chalit Kosolsak, Darshna Kukian, Jitendra Singh Kushwaha, Thelma Laot, Eduardo Lopez-Medina, Hugo Macareno Arroyo, Kishorchandra Mandaliya, Stephanie Mamod, Somnath Mangarule, Javier Martínez, Scott McClelland, Lisa Menard, Sandra Mendoza, Satyajit Mohapatra, Catherine Moreau, Nelly Mugo, Videlis Nduba, Fernando Noriega, Patricia Nahirya Ntege, Brenda Okech, Maria Otero, Samuel Gurrion Ouma, Janet Oyieko, Mercedes Paredes, Erwin Pardo, Svitlana Postol, David Pekala, Penny Peng, Marie-Laure Py, Enrique Rivas, Rafael Rivero, Edith Rodriguez, Mansoor Saleh, Pedro Sánchez, Nessryne Sater, Jinen Shah, Rajeev Shrestha, Abraham Siika, Chandramani Singh, Veer Bahadur Singh, Dipesh Tamrakar, Fernanda Tavares Da-Silva, Lucas Otieno Tina, Hector Velasquez, Deo Wabwire, Anne Wajja, Elodie Zaworski & Nianxian Zhang. (2023) Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial. The Lancet Respiratory Medicine 11:11, pages 975-990.
Crossref
Crossref
Chunxi Wang, Amelia Karlsson, Thomas H. OguinIIIIII, Andrew N. Macintyre, Gregory D. Sempowski, Kevin R. McCarthy, Yifei Wang, M. Anthony Moody & Fan Yuan. (2023) Transient inhibition of lysosomal functions potentiates nucleic acid vaccines. Proceedings of the National Academy of Sciences 120:44.
Crossref
Crossref
Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, Johannes Antony, Amit Suresh Bhate, Tatiana Beresnev, Matthew I. Bonaparte, Médéric Celle, Maria Angeles Ceregido, Lawrence Corey, Bo Fu, Marie-Helene Grillet, Maryam Keshtkar-Jahromi, Michal Juraska, Jia Jin Kee, Seyram Kaali, Marguerite Koutsoukos, Roger Masotti, Nelson L. Michael, Kathleen M. Neuzil, Humberto Reynales, Merlin L. Robb, Akiyoshi Uchiyama, Fredrick Sawe, Lode Schuerman, Rajeev Shrestha, Tina Tong, John Treanor, Carlos A. Diazgranados, Roman M. Chicz, Sanjay Gurunathan, Stephen Savarino, Saranya Sridhar, Karina Abalos, Michael Adams, Mohamed Allaw, Naveena Aloysia, John Humphrey Amuasi, Nana Akosua Ansah, Kwaku Poku Asante, David Benkeser, Aude Berge, Thomas Breuer, Liz Briesemeister, Gail Broder, Alberto Cadena Bonfanti, Cornell Calinescu, Richard Canter, Jaime Augusto Carrillo, Danaya Chansinghakul, Florence Coux, Chandan Das, Matthew Davies, Louis Devlin, Michael Fay, Dean Follmann, Carina Frago, Hiroyuki Fukase, Agnes Garinga, Peter B. Gilbert, Claudia Gonzalez, Maria Angelica Granados, Cathy Greiwe, Lea Guillery, Jessicalee Hall, Jeffrey Henderson, Ying Huang, Kathy Hudzina, John Hural, Mark Hutchens, Manish Jain, William Jennings, Piush Kanodia, Murray Kimmel, William Kirby, Nitin Khandelwal, James Kopp, Chalit Kosolsak, Jim Kublin, Darshna Kukian, Jitendra Singh Kushwaha, Thelma Laot, Eduardo Lopez-Medina, Hugo Macareno Arroyo, Stephanie Mamod, Somnath Mangarule, Troy Martin, Lisa Menard, Sandra Mendoza, Robert Meyer, Randle Middleton, Jill Miracle, Kazuyuki Mizuyama, Satyajit Mohapatra, Catherine Moreau, Linda Murray, Shinya Nagamatsu, Joseph Newberg, Fernando Noriega, Paul Nugent, Michele Peake-Andrasik, David Pekala, Penny Peng, Marie-Laure Py, Shelly Ramirez, Chinthaparthi Prabhakar Reddy, Michelle Reynolds, Enrique Rivas, Nessryne Sater, Jinen Shah, Lawrence Sher, Silva Sieger, Chandramani Singh, Veer Bahadur Singh, Nuchra Sirisuphmitr, Thomas Starkey, Kazuo Suzuki, Dipesh Tamrakar, Cayce Tangemen, Fernanda Tavares Da-Silva, David Taylor, Leslie Tharenos, T. Anh Wartel, Elodie Zaworski & Nianxian Zhang. (2023) Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study. eClinicalMedicine 64, pages 102168.
Crossref
Crossref
Isabela Resende Azevedo, Thais Akemi Amamura & Lourdes Isaac. (2023) Human leptospirosis: In search for a better vaccine. Scandinavian Journal of Immunology.
Crossref
Crossref
Hongze Ren, Wencong Jia, Yujie Xie, Meihua Yu & Yu Chen. (2023) Adjuvant physiochemistry and advanced nanotechnology for vaccine development. Chemical Society Reviews 52:15, pages 5172-5254.
Crossref
Crossref
Francesco Tognetti, Massimiliano Biagini, Maxime Denis, Francesco Berti, Domenico Maione & Daniela Stranges. (2023) Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens. International Journal of Molecular Sciences 24:15, pages 12054.
Crossref
Crossref
Praveen Neeli, Dafei Chai, Xu Wang, Navid Sobhani, George Udeani & Yong Li. (2023) Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2. iScience 26:7, pages 107120.
Crossref
Crossref
Olga A. Krasnova, Vladislav V. Minaychev, Vladimir S. Akatov, Roman S. Fadeev, Anatoly S. Senotov, Margarita I. Kobyakova, Yana V. Lomovskaya, Alexey I. Lomovskiy, Alyona I. Zvyagina, Kirill S. Krasnov, Yuriy V. Shatalin, Nikita V. Penkov, Vitaly K. Zhalimov, Maxim V. Molchanov, Yuliya A. Palikova, Arkady N. Murashev, Eugeny I. Maevsky & Irina S. Fadeeva. (2023) Improving the Stability and Effectiveness of Immunotropic Squalene Nanoemulsion by Adding Turpentine Oil. Biomolecules 13:7, pages 1053.
Crossref
Crossref
James A. Williams, Marco BiancucciLaura Lessen, Sai Tian, Ankita BalsarafLynn ChenChelsy Chesterman, Giulietta Maruggi, Sarah VandepaerYing HuangCorey P. Mallett, Ann-Muriel Steff, Matthew James Bottomley, Enrico Malito, Newton Wahome & Wayne D. Harshbarger. (2023) Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity. Science Advances 9:23.
Crossref
Crossref
Nan Wu, Qiuting Chen, Yongjuan Zou, Chunyu Miao, Guanghui Ma & Jie Wu. (2023) Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type. Carbohydrate Polymers 309, pages 120673.
Crossref
Crossref
Ernesto Garay, Diego Fontana, Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Sebastián Antuña, Belén Tardivo, María Celeste Rodríguez, Victoria Gastaldi, Juan Manuel Battagliotti, Diego Alvarez, Eliana Castro, Juliana Cassataro, Natalia Ceaglio & Claudio Prieto. (2023) Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes. Applied Microbiology and Biotechnology 107:11, pages 3495-3508.
Crossref
Crossref
Halie M. Rando, Ronan Lordan, Alexandra J. Lee, Amruta Naik, Nils Wellhausen, Elizabeth Sell, Likhitha Kolla, Anthony Gitter, Casey S. Greene, Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Jesse G. Meyer, Ariel I. Mundo, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang & Nils Wellhausen. (2023) Application of Traditional Vaccine Development Strategies to SARS-CoV-2. mSystems 8:2.
Crossref
Crossref
Gabriela Polmann, Gerson Lopes Teixeira, Pedro Henrique Santos, Gerardo Álvarez Rivera, Elena Ibañez, Alejandro Cifuentes, Sandra Regina Salvador Ferreira & Jane Mara Block. (2023) Chemical characterization of gurguéia nut (Dipteryx lacunifera Ducke) and press cake oil obtained by hydraulic pressing and supercritical extraction. Biomass Conversion and Biorefinery.
Crossref
Crossref
Elena Canelli, Luca Ferrari, Paolo Borghetti, Francesco Candela, Nkemjika Sopuru Abiakam, Annalisa Bianchera, Francesca Buttini, Gian Enrico Magi, Fabio Sonvico, Paolo Martelli & Ruggero Bettini. (2023) Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens. Frontiers in Veterinary Science 10.
Crossref
Crossref
Carolin Loos, Margherita Coccia, Arnaud M. Didierlaurent, Ahmed Essaghir, Jonathan K. Fallon, Douglas Lauffenburger, Corinne Luedemann, Ashlin Michell, Robbert van der Most, Alex Lee Zhu, Galit Alter & Wivine Burny. (2023) Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. npj Vaccines 8:1.
Crossref
Crossref
Flora Carnet, Laure Perrin-Cocon, Romain Paillot, Vincent Lotteau, Stéphane Pronost & Pierre-Olivier Vidalain. (2023) An inventory of adjuvants used for vaccination in horses: the past, the present and the future. Veterinary Research 54:1.
Crossref
Crossref
Allegra Peletta, Céline Lemoine, Thomas Courant, Nicolas Collin & Gerrit Borchard. (2023) Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines. Pharmacological Research 189, pages 106699.
Crossref
Crossref
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, Shokouh Rezaei, Vuk Uskoković, Mahdi Alijanianzadeh, Vladimir N. Uversky, Seyed Omid Ranaei Siadat, Sina Mozaffari-Jovin & Yahya Sefidbakht. (2023) An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. Progress in Biophysics and Molecular Biology 178, pages 32-49.
Crossref
Crossref
Matthew Tze Jian Wong, Nor Suhada Anuar, Rahmah Noordin & Gee Jun Tye. (2023) Soil-transmitted helminthic vaccines: Where are we now?. Acta Tropica 239, pages 106796.
Crossref
Crossref
Iveta Klojdová, Tomáš Milota, Jitka Smetanová & Constantinos Stathopoulos. (2023) Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?. Pharmaceuticals 16:3, pages 362.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
Xinyuan Chen. (2023) Emerging adjuvants for intradermal vaccination. International Journal of Pharmaceutics 632, pages 122559.
Crossref
Crossref
Kaito Nagashima, Nada Abbadi, Ved Vyas, Abigail Roegner, Ted M. Ross & Jarrod J. Mousa. (2023) Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. Viruses 15:2, pages 347.
Crossref
Crossref
Kentner L. Singleton, Ari Joffe & Wolfgang W. Leitner. (2023) Review: Current trends, challenges, and success stories in adjuvant research. Frontiers in Immunology 14.
Crossref
Crossref
Ning Yang, Xiao Jin, Chenghua Zhu, Fenglin Gao, Zheqi Weng, Xingran Du & Ganzhu Feng. (2023) Subunit vaccines for Acinetobacter baumannii. Frontiers in Immunology 13.
Crossref
Crossref
Rushit N. Lodaya, Amey P. Kanitkar, Asma Ashraf, Douty Bamba, Mansoor M. Amiji & Derek T. O’Hagan. (2023) A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated with a Recombinant Cytomegalovirus (CMV) Pentamer Antigen in Mice. Pharmaceutics 15:1, pages 238.
Crossref
Crossref
Ananya Jain & Shilpa Sharma. 2023. Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022). Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022)
14
26
.
Yoshiyuki Manabe & Koichi Fukase. 2023. Glycolipids. Glycolipids
55
72
.
Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander Makarkov, Gretchen Heizer, Kapil Bhutada, Asif Mahmood, Sonia Trépanier, Karen Hager, Julia Jiang-Wright, Judith Atkins, Pooja Saxena, Matthew P. Cheng, Donald C. Vinh, Philippe Boutet, François Roman, Robbert Van Der Most, Maria Angeles Ceregido, Marc Dionne, Guy Tellier, Jean-Sébastien Gauthier, Brandon Essink, Michael Libman, Jason Haffizulla, André Fréchette, Marc-André D’Aoust, Nathalie Landry & Brian J. Ward. (2022) Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities. npj Vaccines 7:1.
Crossref
Crossref
Tazio Vanni, Beatriz C. Thomé, Erin Sparrow, Martin Friede, Christopher B. Fox, Anna Marie Beckmann, Chuong Huynh, Gabriella Mondini, Daniela H. Silveira, Juliana Y. K. Viscondi, Patrícia Emilia Braga, Anderson da Silva, Maria da Graça Salomão, Roberta O. Piorelli, Joane P. Santos, Vera Lúcia Gattás, Maria Beatriz B. Lucchesi, Mayra M. M. de Oliveira, Marcelo E. Koike, Esper G. Kallas, Lucia M. A. Campos, Eduardo B. Coelho, Marilda A. M. Siqueira, Cristiana C. Garcia, Milene Dias Miranda, Terezinha M. Paiva, Maria do Carmo S. T. Timenetsky, Eduardo A. Adami, Milena A. Akamatsu, Paulo Lee Ho & Alexander R. Precioso. (2022) Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial. PLOS ONE 17:10, pages e0274943.
Crossref
Crossref
Sofia M. Buonocore & Robbert G. van der Most. (2022) Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?. Frontiers in Immunology 13.
Crossref
Crossref
Ying Yin, Yanfei Gu, Xiaodong Zai, Ruihua Li, Xinjie Zhu, Rui Yu, Jun Zhang, Shuyi Wang, Yue Zhang, Jian Lin, Junjie Xu & Wei Chen. (2022) A novel built-in adjuvant metallothionein-3 aids protein antigens to induce rapid, robust, and durable immune responses. Frontiers in Immunology 13.
Crossref
Crossref
Flávia Carneiro Mendes, Janine Cerqueira de Paiva, Elói Quintas Gonçalves da Silva, Marcus Rebouças Santos, Graziela Domingues de Almeida Lima, Gabriela Alves Moreira, Lucas Viana Gomes Silva, Joice de Melo Agripino, Ana Paula Martins de Souza, Tiago Antônio de Oliveira Mendes, Mariana Machado-Neves, Róbson Ricardo Teixeira, Abelardo Silva-Júnior, Juliana Lopes Rangel Fietto, Leandro Licursi de Oliveira & Gustavo Costa Bressan. (2022) Immunomodulatory activity of trifluoromethyl arylamides derived from the SRPK inhibitor SRPIN340 and their potential use as vaccine adjuvant. Life Sciences 307, pages 120849.
Crossref
Crossref
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Alexandra C. Walls, Lauren Carter, David Veesler, Neil P. King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park & Hee Jin Cheong. (2022) Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial. eClinicalMedicine 51, pages 101569.
Crossref
Crossref
Yang Bo & Hua Wang. (2022) Materials‐based vaccines for infectious diseases. WIREs Nanomedicine and Nanobiotechnology 14:5.
Crossref
Crossref
Johannes B. Goll, Aarti Jain, Travis L. Jensen, Rafael Assis, Rie Nakajima, Algis Jasinskas, Lynda Coughlan, Sami R. Cherikh, Casey E. Gelber, S. Khan, D. Huw Davies, Philip Meade, Daniel Stadlbauer, Shirin Strohmeier, Florian Krammer, Wilbur H. Chen & Philip L. Felgner. (2022) The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination. npj Vaccines 7:1.
Crossref
Crossref
Luan Firmino-Cruz, Júlio Souza dos-Santos, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Gustavo Guadagnini-Perez, Victor A. Roncaglia-Pereira, Carlos H. Dumard, Francisca H. Guedes-da-Silva, Ana C. Vicente Santos, Renata G. F. Alvim, Tulio M. Lima, Federico F. Marsili, Daniel P. B. Abreu, Bartira Rossi-Bergmann, Andre M. Vale, Alessandra D’Almeida Filardy, Jerson Lima Silva, Andrea Cheble de Oliveira, Andre M. O. Gomes & Herbert Leonel de Matos Guedes. (2022) Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice. Vaccines 10:8, pages 1305.
Crossref
Crossref
Wei Wang & Defang Ouyang. (2022) Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery. Drug Discovery Today 27:8, pages 2100-2120.
Crossref
Crossref
Lijun Bian, Yu Zheng, Xiaohong Guo, Dongdong Li, Jingying Zhou, Linyao Jing, Yan Chen, Jingcai Lu, Ke Zhang, Chunlai Jiang, Yong Zhang & Wei Kong. (2022) Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice. Frontiers in Immunology 13.
Crossref
Crossref
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, Roya Ghanavati, Moloudsadat Motahar, Mohammad Sholeh, Hossein Ghahramanpour & Saeed Khoshnood. (2022) A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. Frontiers in Microbiology 13.
Crossref
Crossref
Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, Elizabeth B. Lorentz, Jay T. Evans & David J. Burkhart. (2022) Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine. Pharmaceutics 14:7, pages 1455.
Crossref
Crossref
Xuemei Cui, Xiangfei Xu, Pan Huang, Guolian Bao & Yan Liu. (2022) Safety and Efficacy of the Bordetella bronchiseptica Vaccine Combined with a Vegetable Oil Adjuvant and Multi-Omics Analysis of Its Potential Role in the Protective Response of Rabbits. Pharmaceutics 14:7, pages 1434.
Crossref
Crossref
Jenny E. Hernandez-Davies, Emmanuel P. Dollinger, Egest J. Pone, Jiin Felgner, Li Liang, Shirin Strohmeier, Sharon Jan, Tyler J. Albin, Aarti Jain, Rie Nakajima, Algimantas Jasinskas, Florian Krammer, Aaron Esser-Kahn, Philip L. Felgner, Qing Nie & D. Huw Davies. (2022) Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants. Scientific Reports 12:1.
Crossref
Crossref
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Crossref
Balram Ji Omar, Arpana Singh, Vanya Singh, Ashish Kothari & Manju O. Pai. (2022) SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges. Exploration of Immunology, pages 245-263.
Crossref
Crossref
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, Agustin Bueso, Anne-Laure Chabanon, Aiying Chen, Roman M Chicz, David Diemert, Brandon J Essink, Bo Fu, Nicole A Grunenberg, Helene Janosczyk, Michael C Keefer, Doris M Rivera M, Ya Meng, Nelson L Michael, Sonal S Munsiff, Onyema Ogbuagu, Vanessa N Raabe, Randall Severance, Enrique Rivas, Natalya Romanyak, Nadine G Rouphael, Lode Schuerman, Lawrence D Sher, Stephen R Walsh, Judith White, Dalia von Barbier, Guy de Bruyn, Richard Canter, Marie-Helene Grillet, Maryam Keshtkar-Jahromi, Marguerite Koutsoukos, Denise Lopez, Roger Masotti, Sandra Mendoza, Catherine Moreau, Maria Angeles Ceregido, Shelly Ramirez, Ansoyta Said, Fernanda Tavares-Da-Silva, Jiayuan Shi, Tina Tong, John Treanor, Carlos A Diazgranados & Stephen Savarino. (2022) Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study. The Lancet Infectious Diseases 22:5, pages 636-648.
Crossref
Crossref
Aroosa Younis Nadeem, Adeeb Shehzad, Salman Ul Islam, Ebtesam A. Al-Suhaimi & Young Sup Lee. (2022) Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines 10:5, pages 713.
Crossref
Crossref
Yasaman EshraghiYasaman VahdaniPegah KarimiMeghdad Abdollahpour-AlitappehAsghar AbdoliMorteza TaghizadehMehdi Mahdavi. (2022)
Immunomodulatory Effects of
α
-Tocopherol on the H1N1 Influenza Vaccine: Improving the Potency and Efficacy of the Influenza Vaccine in Aged Mice
. Viral Immunology 35:3, pages 244-253.
Crossref
Crossref
Jia Tan, Binbin Ding, Bo Teng, Ping'an Ma & Jun Lin. (2022) Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy. Advanced Functional Materials 32:16.
Crossref
Crossref
Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G. Anosova, Dean Huang, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M. Chicz & Valerie Lecouturier. (2022) Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates. Nature Communications 13:1.
Crossref
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Crossref
Sivakumar Ramachandran, Soumya Ranjan Satapathy & Tathagata Dutta. (2022) Delivery Strategies for mRNA Vaccines. Pharmaceutical Medicine 36:1, pages 11-20.
Crossref
Crossref
Sumira Malik, Shristi Kishore, Shradha A. Kumar, Anjali Kumari, Manisha Kumari & Archna Dhasmana. 2022. Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical Sciences. Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical Sciences
494
516
.
Liyan Zhu, Ziyi Han, Yanfei He & Hongxiang Sun. (2022) Caspase-1-Dependent Pyroptosis Mediates Adjuvant Activity of Platycodin D as an Adjuvant for Intramuscular Vaccines. Cells 11:1, pages 134.
Crossref
Crossref
Charlotte Dubé, Sarah Paris-Robidas, Iryna Primakova, Eric Destexhe, Brian J. Ward, Nathalie Landry & Sonia Trépanier. (2022) Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19. Reproductive Toxicology 107, pages 69-80.
Crossref
Crossref
Anita Milicic, Sören Reinke, Joannah Fergusson, Erik B. Lindblad, Aneesh Thakur, George Corby, Stephanie Longet, Sabina Górska, Agnieszka Razim, Kefei Hu, Bror Morein, Marina Luchner, Dennis Christensen, Slavcho Mrenoshki, Sebnem Ercelen Ceylan, Sveinbjorn Gizurarson & Malachy Chigozie Ugwu. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research
223
280
.
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Bassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner & Michael J. McCluskie. 2022. Vaccine Design. Vaccine Design
179
231
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Yun‐Hee Kim, Kee‐Jong Hong, Hun Kim & Jae‐Hwan Nam. (2021) Influenza vaccines: Past, present, and future. Reviews in Medical Virology 32:1.
Crossref
Crossref
Stephen C De Rosa, Kristen W Cohen, Matthew Bonaparte, Bo Fu, Sanjay Garg, Catherine Gerard, Paul A Goepfert, Ying Huang, Daniel Larocque, M. Juliana McElrath, Daryl Morris, Robbert Van der Most, Guy de Bruyn & Anke Pagnon. (2022) Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate. Clinical & Translational Immunology 11:1.
Crossref
Crossref
Fang Liu, Minmin Wu, Jie Wang, Hongyang Wen, Ran An, Haijian Cai, Li Yu, Jilong Shen, Lijian Chen & Jian Du. (2021) Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Recombinant Toxoplasma gondii MIF, CDPK3, and 14-3-3 Protein Cocktail Vaccine. Frontiers in Immunology 12.
Crossref
Crossref
Ling-xiao Zhang & Zhi Ping Xu. 2021. Biomedical Applications of Inorganic Materials. Biomedical Applications of Inorganic Materials
305
360
.
Chang Keun Kang, Sun-Wook Jeong, Jae-Hwan Jo, Jeong-Ho Park, Min Sik Kim, Jung Eun Yang & Yong Jun Choi. (2021)
High-Level Squalene Production from Methane Using a Metabolically Engineered
Methylomonas
sp. DH-1 Strain
. ACS Sustainable Chemistry & Engineering 9:48, pages 16485-16493.
Crossref
Crossref
Ana Sara Cordeiro, Yogita Patil-Sen, Maitreyi Shivkumar, Ronak Patel, Abdulwahhab Khedr & Mohamed A. Elsawy. (2021) Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 13:12, pages 2091.
Crossref
Crossref
Wasim A. Prates-Syed, Lorena C. S. Chaves, Karin P. Crema, Larissa Vuitika, Aline Lira, Nelson Côrtes, Victor Kersten, Francisco E. G. Guimarães, Mohammad Sadraeian, Fernando L. Barroso da Silva, Otávio Cabral-Marques, José A. M. Barbuto, Momtchilo Russo, Niels O. S. Câmara & Gustavo Cabral-Miranda. (2021) VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants. Vaccines 9:12, pages 1409.
Crossref
Crossref
Saoussane Khalifa, Masaru Enomoto, Shunji Kato & Kiyotaka Nakagawa. (2021) Novel Photoinduced Squalene Cyclic Peroxide Identified, Detected, and Quantified in Human Skin Surface Lipids. Antioxidants 10:11, pages 1760.
Crossref
Crossref
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Tong Ye, Feng Li, Guanghui Ma & Wei Wei. (2021) Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors. Advanced Drug Delivery Reviews 177, pages 113927.
Crossref
Crossref
Jong-Woo Lim, Yu-Rim Ahn, Geunseon Park, Hyun-Ouk Kim & Seungjoo Haam. (2021) Application of Nanomaterials as an Advanced Strategy for the Diagnosis, Prevention, and Treatment of Viral Diseases. Pharmaceutics 13:10, pages 1570.
Crossref
Crossref
Puna Maya Maharjan & Sunghwa Choe. (2021) Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines. Vaccines 9:9, pages 992.
Crossref
Crossref
Matilde Durán-Lobato, Ana María López-Estévez, Ana Sara Cordeiro, Tamara G. Dacoba, José Crecente-Campo, Dolores Torres & María José Alonso. (2021) Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Advanced Drug Delivery Reviews 176, pages 113899.
Crossref
Crossref
Paul A Goepfert, Bo Fu, Anne-Laure Chabanon, Matthew I Bonaparte, Matthew G Davis, Brandon J Essink, Ian Frank, Owen Haney, Helene Janosczyk, Michael C Keefer, Marguerite Koutsoukos, Murray A Kimmel, Roger Masotti, Stephen J Savarino, Lode Schuerman, Howard Schwartz, Lawrence D Sher, Jon Smith, Fernanda Tavares-Da-Silva, Sanjay Gurunathan, Carlos A DiazGranados & Guy de Bruyn. (2021) Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study. The Lancet Infectious Diseases 21:9, pages 1257-1270.
Crossref
Crossref
Soo-Kyung Jeong, Yoon-Ki Heo, Jei-Hyun Jeong, Su-Jin Ham, Jung-Sun Yum, Byung-Cheol Ahn, Chang-Seon Song & Eun-Young Chun. (2021) COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity. Vaccines 9:9, pages 957.
Crossref
Crossref
Joseph R. Francica, Barbara J. FlynnKathryn E. Foulds, Amy T. Noe, Anne P. WernerIan N. Moore, Matthew Gagne, Timothy S. Johnston, Courtney TuckerRachel L. DavisBritta FlachSarah O’ConnellShayne F. Andrew, Evan Lamb, Dillon R. FlebbeSaule T. NurmukhambetovaMitzi M. DonaldsonJohn-Paul M. Todd, Alex Lee Zhu, Caroline Atyeo, Stephanie Fischinger, Matthew J GormanSally Shin, Venkata Viswanadh Edara, Katharine Floyd, Lilin LaiSeyhan Boyoglu-BarnumRenee Van De Wetering, Alida Tylor, Elizabeth McCarthy, Valerie Lecouturier, Sophie Ruiz, Catherine Berry, Timothy Tibbitts, Hanne Andersen, Anthony CookAlan Dodson, Laurent Pessaint, Alex Van Ry, Marguerite Koutsoukos, Cindy GutzeitI.-Ting TengTongqing Zhou, Dapeng LiBarton F. Haynes, Peter D. Kwong, Adrian McDermott, Mark G. Lewis, Tong Ming Fu, Roman ChiczRobbert van der Most, Kizzmekia S. Corbett, Mehul S. Suthar, Galit Alter, Mario Roederer, Nancy J. Sullivan, Daniel C. DouekBarney S. Graham, Danilo CasimiroRobert A. Seder. (2021) Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Science Translational Medicine 13:607.
Crossref
Crossref
Jonah Clegg, Elisabetta Soldaini, Rachel M. McLoughlin, Stephen Rittenhouse, Fabio Bagnoli & Sanjay Phogat. (2021) Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies. Frontiers in Immunology 12.
Crossref
Crossref
Florian Wimmers, Michele Donato, Alex Kuo, Tal Ashuach, Shakti Gupta, Chunfeng Li, Mai Dvorak, Mariko Hinton Foecke, Sarah E. Chang, Thomas Hagan, Sanne E. De Jong, Holden T. Maecker, Robbert van der Most, Peggie Cheung, Mario Cortese, Steven E. Bosinger, Mark Davis, Nadine Rouphael, Shankar Subramaniam, Nir Yosef, Paul J. Utz, Purvesh Khatri & Bali Pulendran. (2021) The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell 184:15, pages 3915-3935.e21.
Crossref
Crossref
Manu Kumar, Nisha Kumari, Nishant Thakur, Shashi Kant Bhatia, Ganesh Dattatraya Saratale, Gajanan Ghodake, Bhupendra M. Mistry, Hemasundar Alavilli, D. S. Kishor, Xueshi Du & Sang-Min Chung. (2021) A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics. Plants 10:6, pages 1213.
Crossref
Crossref
Ivana Ruseska, Katja Fresacher, Christina Petschacher & Andreas Zimmer. (2021) Use of Protamine in Nanopharmaceuticals—A Review. Nanomaterials 11:6, pages 1508.
Crossref
Crossref
Adam M. Sandor, Michael S. Sturdivant & Jenny P. Y. Ting. (2021) Influenza Virus and SARS-CoV-2 Vaccines. The Journal of Immunology 206:11, pages 2509-2520.
Crossref
Crossref
Bali Pulendran, Prabhu S. Arunachalam & Derek T. O’Hagan. (2021) Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery 20:6, pages 454-475.
Crossref
Crossref
Toshiki Sekiya, Marumi Ohno, Naoki Nomura, Chimuka Handabile, Masashi Shingai, David C. Jackson, Lorena E. Brown & Hiroshi Kida. (2021) Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses 13:6, pages 971.
Crossref
Crossref
Anders Madsen, Åsne Jul-Larsen, Mai-Chi Trieu, Florian Krammer & Rebecca J. Cox. (2021) Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response. npj Vaccines 6:1.
Crossref
Crossref
Maryam Behzadi, Bahareh Vakili, Alireza Ebrahiminezhad & Navid Nezafat. (2021) Iron nanoparticles as novel vaccine adjuvants. European Journal of Pharmaceutical Sciences 159, pages 105718.
Crossref
Crossref
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman & Bhavesh D. Kevadiya. (2021) Nanocarrier vaccines for SARS-CoV-2. Advanced Drug Delivery Reviews 171, pages 215-239.
Crossref
Crossref
Kaito A. Nagashima & Jarrod J. Mousa. (2021) Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine. Viruses 13:4, pages 546.
Crossref
Crossref
Daniel Stadlbauer, Leon de Waal, Edith Beaulieu, Shirin Strohmeier, Edwin J. B. Veldhuis Kroeze, Philippe Boutet, Albert D. M. E. Osterhaus, Florian Krammer, Bruce L. Innis, Raffael Nachbagauer, Koert J. Stittelaar & Corey P. Mallett. (2021) AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets. npj Vaccines 6:1.
Crossref
Crossref
Zaid Haddadin, Karen Krueger, Lora D. Thomas, Edgar T. Overton, Michael Ison & Natasha Halasa. (2020) Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. American Journal of Transplantation 21:3, pages 938-949.
Crossref
Crossref
Joshua G. Liang, Danmei Su, Tian-Zhang Song, Yilan Zeng, Weijin Huang, Jinhua Wu, Rong Xu, Peiwen Luo, Xiaofang Yang, Xiaodong Zhang, Shuangru Luo, Ying Liang, Xinglin Li, Jiaju Huang, Qiang Wang, Xueqin Huang, Qingsong Xu, Mei Luo, Anliang Huang, Dongxia Luo, Chenyan Zhao, Fan Yang, Jian-Bao Han, Yong-Tang Zheng & Peng Liang. (2021) S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates. Nature Communications 12:1.
Crossref
Crossref
Nikolaos C. Kyriakidis, Andrés López-Cortés, Eduardo Vásconez González, Alejandra Barreto Grimaldos & Esteban Ortiz Prado. (2021) SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines 6:1.
Crossref
Crossref
Kyung Soo Park, Xiaoqi Sun, Marisa E. Aikins & James J. Moon. (2021) Non-viral COVID-19 vaccine delivery systems. Advanced Drug Delivery Reviews 169, pages 137-151.
Crossref
Crossref
Cole J. Batty, Mark T. Heise, Eric M. Bachelder & Kristy M. Ainslie. (2021) Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection. Advanced Drug Delivery Reviews 169, pages 168-189.
Crossref
Crossref
Zhuofan Li, Yiwen Zhao, Yibo Li & Xinyuan Chen. (2021) Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines 9:2, pages 75.
Crossref
Crossref
Ariel Isaacs, Zheyi Li, Stacey T. M. Cheung, Danushka K. Wijesundara, Christopher L. D. McMillan, Naphak Modhiran, Paul R. Young, Charani Ranasinghe, Daniel Watterson & Keith J. Chappell. (2021) Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines. Vaccines 9:2, pages 71.
Crossref
Crossref
Koichi Fukase. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
166
184
.
N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya & L. A. Gayderova. (2020) General Characteristics of Adjuvants and Their Mechanism of Action (Part 1). BIOpreparations. Prevention, Diagnosis, Treatment 20:4, pages 245-256.
Crossref
Crossref
Yoshiyuki Manabe, Tsung-Che Chang & Koichi Fukase. (2020) Recent advances in self-adjuvanting glycoconjugate vaccines. Drug Discovery Today: Technologies 37, pages 61-71.
Crossref
Crossref
Zhihui Liang, Haoru Zhu, Xin Wang, Bo Jing, Zifan Li, Xinyu Xia, Hongwu Sun, Yun Yang, Weiting Zhang, Li Shi, Hao Zeng & Bingbing Sun. (2020) Adjuvants for Coronavirus Vaccines. Frontiers in Immunology 11.
Crossref
Crossref
Brien K. Haun, Chih-Yun Lai, Caitlin A. Williams, Teri Ann S. Wong, Michael M. Lieberman, Laurent Pessaint, Hanne Andersen & Axel T. Lehrer. (2020) CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. Frontiers in Immunology 11.
Crossref
Crossref
Young Hun Chung, Veronique Beiss, Steven N. Fiering & Nicole F. Steinmetz. (2020) COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano 14:10, pages 12522-12537.
Crossref
Crossref
Dheeraj Soni, Simon D. Van Haren, Olubukola T. Idoko, Jay T. Evans, Joann Diray-Arce, David J. Dowling & Ofer Levy. (2020) Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference. Frontiers in Immunology 11.
Crossref
Crossref
Ekramy E. Sayedahmed, Ahmed Elkashif, Marwa Alhashimi, Suryaprakash Sambhara & Suresh K. Mittal. (2020) Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines. Vaccines 8:4, pages 574.
Crossref
Crossref
Sören Reinke, Aneesh Thakur, Cillian Gartlan, Jelena S. Bezbradica & Anita Milicic. (2020) Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines 8:3, pages 554.
Crossref
Crossref
Yu Zheng, Lijun Bian, Huiting Zhao, Yulan Liu, Jingcai Lu, Dawei Liu, Ke Zhang, Yueshuang Song, Yusi Luo, Chunlai Jiang, Yan Chen, Yong Zhang & Wei Kong. (2020) Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice. Frontiers in Immunology 11.
Crossref
Crossref
Yun-Hee Kim, Yoo-Jin Bang, Hyo-Jung Park, Hae Li Ko, Sang-In Park, Kyung-Ah Hwang, Hun Kim & Jae-Hwan Nam. (2020) Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection. Vaccine 38:39, pages 6141-6152.
Crossref
Crossref
Gabriel N. A. Rego, Mariana P. Nucci, Arielly H. Alves, Fernando A. Oliveira, Luciana C. Marti, Leopoldo P. Nucci, Javier B. Mamani & Lionel F. Gamarra. (2020) Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2. Vaccines 8:3, pages 474.
Crossref
Crossref
Derek T. O’Hagan, Rushit N. Lodaya & Giuseppe Lofano. (2020) The continued advance of vaccine adjuvants – ‘we can work it out’. Seminars in Immunology 50, pages 101426.
Crossref
Crossref
Zhenghui Xu, Tania Rivera-Hernandez & Peter Michael Moyle. (2020) Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein–Fusion Combination Vaccine. ACS Infectious Diseases 6:7, pages 1770-1782.
Crossref
Crossref
Peggy Riese, Stephanie Trittel, Rishi D. Pathirana, Frank Klawonn, Rebecca J. Cox & Carlos A. Guzmán. (2020) Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells. Vaccines 8:2, pages 281.
Crossref
Crossref
Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng & Quanming Zou. (2020) Progress and Prospects on Vaccine Development against SARS-CoV-2. Vaccines 8:2, pages 153.
Crossref
Crossref
Etsuro Nanishi, David J. Dowling & Ofer Levy. (2020) Toward precision adjuvants: optimizing science and safety. Current Opinion in Pediatrics 32:1, pages 125-138.
Crossref
Crossref
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, Raffael Nachbagauer, Francesco Berlanda-Scorza, Jodi Feser, Patrick C Wilson, Alicia Solórzano, Marie Van der Wielen, Emmanuel B Walter, Randy A Albrecht, Kristen N Buschle, Yao-qing Chen, Carine Claeys, Michelle Dickey, Haley L Dugan, Megan E Ermler, Debra Freeman, Min Gao, Christopher Gast, Jenna J Guthmiller, Rong Hai, Carole Henry, Linda Yu-Ling Lan, Monica McNeal, Anna-Karin E Palm, Dustin G Shaw, Christopher T Stamper, Weina Sun, Victoria Sutton, Micah E Tepora, Rahnuma Wahid, Heather Wenzel, Teddy John Wohlbold, Bruce L Innis, Adolfo García-Sastre, Peter Palese & Florian Krammer. (2020) Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. The Lancet Infectious Diseases 20:1, pages 80-91.
Crossref
Crossref
Joon Haeng Rhee. 2020. Mucosal Vaccines. Mucosal Vaccines
325
356
.
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2020. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
285
315
.
Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad A. Behzadi, Damien Friel, Arvind Rajabhathor, Angela Choi, Randy A. Albrecht, Muriel Debois, Adolfo García-Sastre, Ronan N. Rouxel, Weina Sun, Peter Palese, Corey P. Mallett, Bruce L. Innis, Florian Krammer & Carine Claeys. (2019) Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts. npj Vaccines 4:1.
Crossref
Crossref
Rushit N. Lodaya, Amey P. Kanitkar, Kristian Friedrich, Dawn Henson, Ryan Yamagata, Sandra Nuti, Corey P. Mallett, Sylvie Bertholet, Mansoor M. Amiji & Derek T. O’Hagan. (2019) Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine. Journal of Controlled Release 316, pages 12-21.
Crossref
Crossref
Kristopher K. Short, Shannon M. Miller, Lois Walsh, Van Cybulski, Hélène Bazin, Jay T. Evans & David Burkhart. (2019) Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity. Journal of Controlled Release 315, pages 186-196.
Crossref
Crossref
Million A. Tegenge, Linda S. Von Tungeln, Steven A. Anderson, Robert J. Mitkus, Michelle M. Vanlandingham, Richard A. Forshee & Frederick A. Beland. (2019) Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines. Regulatory Toxicology and Pharmacology 108, pages 104436.
Crossref
Crossref
Soyoung Kim & Eunok Jung. (2019) Prioritization of vaccine strategy using an age-dependent mathematical model for 2009 A/H1N1 influenza in the Republic of Korea. Journal of Theoretical Biology 479, pages 97-105.
Crossref
Crossref
Chung-Hsiung Huang, Chiung-Yi Huang & Ming-Hsi Huang. (2019) Impact of antigen-adjuvant associations on antigen uptake and antigen-specific humoral immunity in mice following intramuscular injection. Biomedicine & Pharmacotherapy 118, pages 109373.
Crossref
Crossref
Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice, Arnaud M. Didierlaurent & Fernanda Tavares Da Silva. (2019) The how’s and what’s of vaccine reactogenicity. npj Vaccines 4:1.
Crossref
Crossref
Jay T. Evans, Laura S. Bess, Sandra C. Mwakwari, Mark T. Livesay, Yufeng Li, Van Cybulski, David A. Johnson & Hélène G. Bazin. (2019) Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series. ACS Omega 4:13, pages 15665-15677.
Crossref
Crossref
Nor Azrini Nadiha Azmi, Amal A. M. Elgharbawy, Shiva Rezaei Motlagh, Nurhusna Samsudin & Hamzah Mohd. Salleh. (2019) Nanoemulsions: Factory for Food, Pharmaceutical and Cosmetics. Processes 7:9, pages 617.
Crossref
Crossref
Béatrice Laupèze, Caroline Hervé, Alberta Di Pasquale & Fernanda Tavares Da Silva. (2019) Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. Vaccine 37:38, pages 5670-5680.
Crossref
Crossref
Stephen N. Crooke, Inna G. Ovsyannikova, Gregory A. Poland & Richard B. Kennedy. (2019) Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses. Experimental Gerontology 124, pages 110632.
Crossref
Crossref
Mansi Sharma, Florian Krammer, Adolfo García-Sastre & Shashank Tripathi. (2019) Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era. Vaccines 7:3, pages 89.
Crossref
Crossref
Anders Madsen, Linda Azimi, Sarah Tete, Fan Zhou, Florian Krammer, Rebecca Jane Cox & Åsne Jul-Larsen. (2019) No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination. Vaccine: X 2, pages 100029.
Crossref
Crossref
Aline F. Teixeira, Luis G.V. Fernandes, Maria F. Cavenague, Maria B. Takahashi, Jademilson C. Santos, Felipe J. Passalia, Brenda B. Daroz, Leandro T. Kochi, Monica L. Vieira & Ana L.T.O. Nascimento. (2019) Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines. Vaccine 37:30, pages 3961-3973.
Crossref
Crossref
Min Z. Levine, Crystal Holiday, Stacie Jefferson, F. Liaini Gross, Feng Liu, Sheng Li, Damien Friel, Philippe Boutet, Bruce L. Innis, Corey P. Mallett, Terrence M. Tumpey, James Stevens & Jacqueline M. Katz. (2019) Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost. npj Vaccines 4:1.
Crossref
Crossref
Lumena Louis, Megan C. Wise, Hyeree Choi, Daniel O. Villarreal, Kar Muthumani & David B. Weiner. (2019) Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model. Vaccines 7:2, pages 42.
Crossref
Crossref
Leigh M Howard, Johannes B Goll, Travis L Jensen, Kristen L Hoek, Nripesh Prasad, Casey E Gelber, Shawn E Levy, Sebastian Joyce, Andrew J Link, C Buddy Creech & Kathryn M Edwards. (2019) AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells. The Journal of Infectious Diseases 219:11, pages 1786-1798.
Crossref
Crossref
Shuting Shi, Haoru Zhu, Xinyu Xia, Zhihui Liang, Xuehu Ma & Bingbing Sun. (2019) Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity. Vaccine 37:24, pages 3167-3178.
Crossref
Crossref
Catherine Cohet, Robbert van der Most, Vincent Bauchau, Rafik Bekkat-Berkani, T. Mark Doherty, Anne Schuind, Fernanda Tavares Da Silva, Rino Rappuoli, Nathalie Garçon & Bruce L. Innis. (2019) Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. Vaccine 37:23, pages 3006-3021.
Crossref
Crossref
Angela Choi, Badiaa Bouzya, Klaus-Daniel Cortés Franco, Daniel Stadlbauer, Arvind Rajabhathor, Ronan N. Rouxel, Roland Mainil, Marie Van der Wielen, Peter Palese, Adolfo García-Sastre, Bruce L. Innis, Florian Krammer, Michael Schotsaert, Corey P. Mallett & Raffael Nachbagauer. (2019) Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice. ImmunoHorizons 3:4, pages 133-148.
Crossref
Crossref
Janine K. Tom, Tyler J. Albin, Saikat Manna, Brittany A. Moser, Rachel C. Steinhardt & Aaron P. Esser-Kahn. (2019) Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development. Trends in Biotechnology 37:4, pages 373-388.
Crossref
Crossref
Mai-Chi Trieu, Åsne Jul-Larsen, Marianne Sævik, Anders Madsen, Jane Kristin Nøstbakken, Fan Zhou, Steinar Skrede & Rebecca Jane Cox. (2019) Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study. Clinical Infectious Diseases 68:3, pages 382-392.
Crossref
Crossref
César Parra-Rojas, Veronika von Messling & Esteban A. Hernandez-Vargas. (2019) Adjuvanted influenza vaccine dynamics. Scientific Reports 9:1.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2018. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
1
31
.
Lumena Louis & David B. Weiner. 2019. Microbiome and Cancer. Microbiome and Cancer
347
362
.
Annalisa Ciabattini, Christine Nardini, Francesco Santoro, Paolo Garagnani, Claudio Franceschi & Donata Medaglini. (2018) Vaccination in the elderly: The challenge of immune changes with aging. Seminars in Immunology 40, pages 83-94.
Crossref
Crossref
Ting Liu, Rui Qian, Qingchuan Liu, Tingni Wu & Jialong Chen. 2018. Immunization - Vaccine Adjuvant Delivery System and Strategies. Immunization - Vaccine Adjuvant Delivery System and Strategies.
Hossam H Tayeb & Frank Sainsbury. (2018) Nanoemulsions in drug delivery: formulation to medical application. Nanomedicine 13:19, pages 2507-2525.
Crossref
Crossref
Surender Khurana, Elizabeth M. Coyle, Jody Manischewitz, Lisa R. King, Jin Gao, Ronald N. Germain, Pamela L. Schwartzberg, John S. Tsang, Hana Golding, Angelique Biancotto, Julián Candia, Jinguo Chen, Foo Cheung, Howard Dickler, Yuri Kotliarov, Shira Perl, Rongye Shi, Katherine E. R. Stagliano, Neal S. Young & Huizhi Zhou. (2018) AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization. npj Vaccines 3:1.
Crossref
Crossref
Ali M. Harandi. (2018) Systems analysis of human vaccine adjuvants. Seminars in Immunology 39, pages 30-34.
Crossref
Crossref
Giuseppe Del Giudice, Rino Rappuoli & Arnaud M. Didierlaurent. (2018) Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Seminars in Immunology 39, pages 14-21.
Crossref
Crossref
Yangjie Wei, Jian Xiong, Nicholas R. Larson, Vidyashankara Iyer, Gautam Sanyal, Sangeeta B. Joshi, David B. Volkin & C. Russell Middaugh. (2018) Effect of 2 Emulsion-Based Adjuvants on the Structure and Thermal Stability of Staphylococcus aureus Alpha-Toxin. Journal of Pharmaceutical Sciences 107:9, pages 2325-2334.
Crossref
Crossref
José Crecente-Campo, Silvia Lorenzo-Abalde, Azucena Mora, Juan Marzoa, Noemi Csaba, Jorge Blanco, África González-Fernández & María José Alonso. (2018) Bilayer polymeric nanocapsules: A formulation approach for a thermostable and adjuvanted E. coli antigen vaccine. Journal of Controlled Release 286, pages 20-32.
Crossref
Crossref
Tatyana A. Kuznetsova, Elena V. Persiyanova, Svetlana P. Ermakova, Maxim Yu. Khotimchenko & Natalya N. Besednova. (2018) The Sulfated Polysaccharides of Brown Algae and Products of Their Enzymatic Transformation as Potential Vaccine Adjuvants. Natural Product Communications 13:8, pages 1934578X1801300.
Crossref
Crossref
Wei Shi, Yiming Kou, Jinghui Xiao, Lijuan Zhang, Feng Gao, Wei Kong, Weiheng Su, Chunlai Jiang & Yong Zhang. (2018) Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants. Vaccine 36:33, pages 5020-5029.
Crossref
Crossref
Charlotte Givord, Iain Welsby, Sophie Detienne, Séverine Thomas, Assiya Assabban, Viviana Lima Silva, Céline Molle, Romain Gineste, Marjorie Vermeersch, David Perez-Morga, Oberdan Leo, Catherine Collignon, Arnaud M. Didierlaurent & Stanislas Goriely. (2018) Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties. npj Vaccines 3:1.
Crossref
Crossref
Zhenghui Xu & Peter Michael Moyle. (2017) Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands. Bioconjugate Chemistry 29:3, pages 572-586.
Crossref
Crossref
Raffael Nachbagauer, Wen-Chun Liu, Angela Choi, Teddy John Wohlbold, Talia Atlas, Madhusudan Rajendran, Alicia Solórzano, Francesco Berlanda-Scorza, Adolfo García-Sastre, Peter Palese, Randy A. Albrecht & Florian Krammer. (2017) A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. npj Vaccines 2:1.
Crossref
Crossref
Srinivasa Reddy Bonam, Charalambos D. Partidos, Sampath Kumar M. Halmuthur & Sylviane Muller. (2017) An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. Trends in Pharmacological Sciences 38:9, pages 771-793.
Crossref
Crossref
Amy S McKee & Philippa Marrack. (2017) Old and new adjuvants. Current Opinion in Immunology 47, pages 44-51.
Crossref
Crossref
Thomas Courant, Emilie Bayon, Hei Lanne Reynaud-Dougier, Christian Villiers, Mathilde Menneteau, Patrice N. Marche & Fabrice P. Navarro. (2017) Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies. Biomaterials 136, pages 29-42.
Crossref
Crossref
Vidyashankara Iyer, Corinne Cayatte, Jason D. Marshall, Jenny Sun, Kirsten Schneider-Ohrum, Sean K. Maynard, Gaurav Manohar Rajani, Angie Snell Bennett, Richard L. RemmeleJr.Jr., Steve M. Bishop, Michael P. McCarthy & Bilikallahalli K. Muralidhara. (2017) Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products. Journal of Pharmaceutical Sciences 106:6, pages 1490-1498.
Crossref
Crossref
Allison C. Galassie, Johannes B. Goll, Parimal Samir, Travis L. Jensen, Kristen L. Hoek, Leigh M. Howard, Tara M. Allos, Xinnan Niu, Laura E. Gordy, C. Buddy Creech, Heather Hill, Sebastian Joyce, Kathryn M. Edwards & Andrew J. Link. (2017) Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination. PROTEOMICS 17:12, pages 1600453.
Crossref
Crossref
Ariane Gomes, Mona Mohsen & Martin Bachmann. (2017) Harnessing Nanoparticles for Immunomodulation and Vaccines. Vaccines 5:1, pages 6.
Crossref
Crossref
Sandra Fuentes, Laura Klenow, Hana Golding & Surender Khurana. (2017) Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model. Scientific Reports 7:1.
Crossref
Crossref
Leigh M. Howard, Kristen L. Hoek, Johannes B. Goll, Parimal Samir, Allison Galassie, Tara M. Allos, Xinnan Niu, Laura E. Gordy, C. Buddy Creech, Nripesh Prasad, Travis L. Jensen, Heather Hill, Shawn E. Levy, Sebastian Joyce, Andrew J. Link & Kathryn M. Edwards. (2017) Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial. PLOS ONE 12:1, pages e0167488.
Crossref
Crossref
Birgit Weinberger. 2017. The Ageing Immune System and Health. The Ageing Immune System and Health
69
86
.
Jean Haensler. 2017. Vaccine Adjuvants. Vaccine Adjuvants
165
180
.
Ruchi R. Shah, Kimberly J. Hassett & Luis A. Brito. 2017. Vaccine Adjuvants. Vaccine Adjuvants
1
13
.
Anthony L. Cunningham, Nathalie Garçon, Oberdan Leo, Leonard R. Friedland, Richard Strugnell, Béatrice Laupèze, Mark Doherty & Peter Stern. (2016) Vaccine development: From concept to early clinical testing. Vaccine 34:52, pages 6655-6664.
Crossref
Crossref
J. D. Galson, J. Trück, D. F. Kelly & R. van der Most. (2016) Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination. Scientific Reports 6:1.
Crossref
Crossref
Million A. Tegenge, Linda S. Von Tungeln, Robert J. Mitkus, Steven A. Anderson, Michelle M. Vanlandingham, Richard A. Forshee & Frederick A. Beland. (2016) Pharmacokinetics and biodistribution of squalene-containing emulsion adjuvant following intramuscular injection of H5N1 influenza vaccine in mice. Regulatory Toxicology and Pharmacology 81, pages 113-119.
Crossref
Crossref
Rebecca Schmidt, Edgar Holznagel, Britta Neumann, Nina Alex, Bevan Sawatsky, Theresa Enkirch, Kristin Pfeffermann, Carina Kruip, Veronika von Messling & Ralf Wagner. (2016) Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase. Vaccine 34:44, pages 5329-5335.
Crossref
Crossref
Weiping Cao, William G. Davis, Jin Hyang Kim, Juan A. De La Cruz, Andrew Taylor, Grant R. Hendrickson, Amrita Kumar, Priya Ranjan, L. Andrew Lyon, Jacqueline M. Katz, Shivaprakash Gangappa & Suryaprakash Sambhara. (2016) An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice. Nanomedicine: Nanotechnology, Biology and Medicine 12:7, pages 1909-1917.
Crossref
Crossref
Raffael Nachbagauer, David Kinzler, Angela Choi, Ariana Hirsh, Edith Beaulieu, Nicolas Lecrenier, Bruce L Innis, Peter Palese, Corey P Mallett & Florian Krammer. (2016) A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice. npj Vaccines 1:1.
Crossref
Crossref
Shawn R. Makinen, Qin Zhu, Heather L. Davis & Risini D. Weeratna. (2016) CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE). International Immunology 28:9, pages 453-461.
Crossref
Crossref
Chuan Wang, Matthew Hart, Cecilia Chui, Augustine Ajuogu, Iona J. Brian, Simone C. de Cassan, Persephone Borrow, Simon J. Draper & Alexander D. Douglas. (2016) Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines. The Journal of Immunology 197:4, pages 1242-1251.
Crossref
Crossref
Cecilia Buonsanti, Cristiana Balocchi, Carole Harfouche, Federica Corrente, Luisa Galli Stampino, Francesca Mancini, Marta Tontini, Padma Malyala, Simone Bufali, Barbara Baudner, Ennio De Gregorio, Nicholas M. Valiante, Derek T. O’Hagan, Rino Rappuoli & Ugo D’Oro. (2016) Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines. Scientific Reports 6:1.
Crossref
Crossref
Karen K. Yam, Jyotsana Gupta, Elizabeth K. Allen, Kayla R. Burt, Édith Beaulieu, Corey P. Mallett, David S. Burt & Brian J. Ward. (2016) Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice. Vaccine 34:12, pages 1444-1451.
Crossref
Crossref
Ji In Ryu, Shin Ae Park, Seo Ri Wui, Ara Ko, Ji Eun Han, Jung Ah Choi, Man Ki Song, Kwang Sung Kim, Yang Je Cho & Na Gyong Lee. (2016)
A De-
O
-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice
. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Fernanda Caroline Coirada, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2016)
Adjuvants: Classification,
Modus Operandi
, and Licensing
. Journal of Immunology Research 2016, pages 1-16.
Crossref
Crossref
Takami Akagi & Mitsuru Akashi. 2016. Nanomaterials in Pharmacology. Nanomaterials in Pharmacology
439
455
.
Lawrence Segal, Sandrine Wouters, Danielle Morelle, Gaëlle Gautier, Julien Le Gal, Thomas Martin, Frieke Kuper, Eric Destexhe, Arnaud M. Didierlaurent & Nathalie Garçon. (2015) Non-clinical safety and biodistribution of AS03-adjuvanted inactivated pandemic influenza vaccines. Journal of Applied Toxicology 35:12, pages 1564-1576.
Crossref
Crossref
Lawrence Segal, Virginie Roger, Colin Williams, Eric Destexhe & Nathalie Garçon. (2015) Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats. Regulatory Toxicology and Pharmacology 73:1, pages 116-125.
Crossref
Crossref
Displaying 200 of 241 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list